Table 3 Weight and height z-scores according to month since start of treatment and average CS dose in period
Average dose in previous period | Period (months from start) | |||
|---|---|---|---|---|
0–11 | 12–47 | 48–71 | 72+ | |
Weight z-score change since baseline | ||||
0–0.4 mg/kg | ||||
Number of persons | 332 | 52 | 31 | 21 |
Average (SD) | −0.24 (0.32) | −0.26 (0.70) | −0.15 (1.04) | −0.32 (0.90) |
0.5–1.4 mg/kg | ||||
Number of persons | 271 | 165 | 83 | |
Average (SD) | −0.51 (0.64) | −0.48 (0.89) | −0.25 (1.00) | |
1.5+ mg/kg | ||||
Number of persons | 6 | 4 | 1 | |
Average (SD) | −0.61 (0.21) | −0.93 (0.13) | −1.47 (0.00) | |
Height z-score change since baseline | ||||
0–0.4 mg/kg | ||||
Number of persons | 331 | 51 | 30 | 21 |
Average (SD) | −0.08 (0.20) | −0.15 (0.41) | −0.16 (0.71) | −0.44 (0.60) |
0.5–1.4 mg/kg | ||||
Number of persons | 271 | 165 | 83 | |
Average (SD) | −0.28 (0.44) | −0.47 (0.64) | −0.51 (0.75) | |
1.5+ mg/kg | ||||
Number of persons | 6 | 47 | 1 | |
Average (SD) | −0.43 (0.25) | −0.89 (0.45) | −0.12 (0.00) | |